Arbutus Biopharma Corp (ABUS) Reports Q3 2023 Financial Results
Company continues clinical trials and reduces workforce by 24% amidst pipeline optimization
Michaelj Mcelhaugh William Collier Company Board Of Directors Arbutus Biopharma Corp Biopharma Corp American Association
Source: yahoo.com